Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeting mRNA-coding genes in prostate cancer using CRISPR/Cas9 technology with a special focus on androgen receptor signaling

17 Oct 2024

Abstract excerpt

BACKGROUND: Prostate cancer is among prevalent cancers in men. Numerous strategies have been proposed to intervene with the important prostate cancer-related signaling pathways. Among the most promising strategies is CRISPR/Cas9 strategy. This strategy has been used to modify expression of a number of genes in prostate cancer cells. AIMS: This review summarizes the most recent progresses in the application of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Prostate Cancer Diagnosis and Treatment
Share to Prostate Cancer Treatment and Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39420406
DOI: 10.1186/s12964-024-01833-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeting mRNA-coding genes in prostate cancer using CRISPR/Cas9 technology with a special focus on androgen receptor signalingPMID 39420406Read ↗

CRISPR Screen Contributes to Novel Target Discovery in Prostate CancerSemantic proximity Read ↗

CRISPR/Cas9 Technology Providing a Therapeutic Landscape of Metastatic Prostate CancerSemantic proximity Read ↗

Targeting AP-1 transcription factors by CRISPR in the prostateSemantic proximity Read ↗

CRISPR-Cas9 ERβ deletion reveals roles in prostate.Semantic proximity Read ↗

Integrative CRISPR-Cas9 Screening Reveals Lethal Genes Driving Metastasis and Prognosis in Prostate AdenocarcinomaSemantic proximity Read ↗

Targeting the MALAT1 gene with the CRISPR/Cas9 technique in prostate cancerSemantic proximity Read ↗

Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for interventionSemantic proximity Read ↗

Application and new findings of scRNA-seq and ST-seq in prostate cancerSemantic proximity Read ↗

Molecular Mechanisms of Prostate Cancer Development in the Precision Medicine Era: A Comprehensive ReviewSemantic proximity Read ↗

FOXA1 knock-out via CRISPR/Cas9 altered Casp-9, Bax, CCND1, CDK4, and fibronectin expressions in LNCaP cells.Semantic proximity Read ↗

Interactions between key genes and pathways in prostate cancer progression and therapy resistanceSemantic proximity Read ↗

CRISPR screening reveals gleason score and castration resistance related oncodriver ring finger protein 19 A (RNF19A) in prostate cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.